941 top medical experts on Granulomatosis with Polyangiitis across 48 countries and 35 U.S. states, including 851 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Granulomatosis with Polyangiitis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (vasculitis) leading to damage in any number of organs. The common features include granulomatous inflammation of the respiratory tract and kidneys. Most patients have measurable autoantibodies (antineutrophil cytoplasmic antibodies) against myeloblastin.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Interstitial Lung Diseases (4,640), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1,812).
- Clinical Trials : at least 90 including 6 Active, 45 Completed, 14 Recruiting
- Synonyms: Wegener's Granulomatosis, Wegener Granulomatosis
- Specks, Ulrich Pulmonary DiseaseDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA. Top HospitalSubjects: Microscopic Polyangiitis; Churg-Strauss Syndrome; Antibodies, Antineutrophil Cytoplasmic; Myeloblastin; Immunosuppressive AgentsCategories: Immunology; Drug Therapy; Genetics; Metabolism; Therapeutic Use; Complications
- Merkel, Peter A RheumatologyDivision of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA. Top HospitalMedical school: Yale University School of Medicine (MD, 1988)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100Disclosed payments in 2021 from 7 biomedical companies, totalling $11,692, including $5,192 from Novartis Pharma AGSubjects: Microscopic Polyangiitis; Churg-Strauss Syndrome; Immunosuppressive Agents; Eosinophilic Granuloma; Antibodies, Antineutrophil CytoplasmicCategories: Genetics; Diagnosis; Drug Therapy; Immunology; Therapeutic Use; Metabolism
- Langford, Carol A RheumatologyDivision of Rheumatology, Cleveland Clinic, Cleveland, OH, USA.Medical school: University of California, Geffen School of Medicine (MD, 1987)Medicare AcceptedDisclosed payments from biomedical company (Axonics, Inc.) in 2021 for $76.59Subjects: Microscopic Polyangiitis; Immunosuppressive Agents; Churg-Strauss Syndrome; Antibodies, Monoclonal, Murine-Derived; Antibodies, Antineutrophil CytoplasmicCategories: Therapeutic Use; Genetics; Drug Therapy; Immunology; Epidemiology; Blood
- Stone, John H RheumatologyMassachusetts General Hospital, Boston, Massachusetts, USA. Top HospitalDisclosed payments in 2021 from 12 biomedical companies, totalling $22,954.4, including $10,736.25 from SANOFI-AVENTIS U.S. LLCSubjects: Microscopic Polyangiitis; Antibodies, Antineutrophil Cytoplasmic; Immunoglobulin G; Kidney Failure, Chronic; Immunosuppressive AgentsCategories: Genetics; Immunology; Drug Therapy; Diagnosis; Therapeutic Use; Metabolism
- Spiera, Robert F RheumatologyHospital for Special Surgery, New York, New York, USA.Medical school: Yale University School of Medicine (MD, 1989)Medicare AcceptedDisclosed payments in 2021 from 4 biomedical companies, totalling $3,033.42, including $1,600 from AbbVie Inc.Subjects: Microscopic Polyangiitis; Immunosuppressive Agents; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Murine-Derived; CyclophosphamideCategories: Genetics; Drug Therapy; Immunology; Therapeutic Use; Adverse Effects; Diagnosis
- Monach, Paul A RheumatologyDivision of Rheumatology, Brigham and Womens Hospital, Boston, MA, USA. Top HospitalSubjects: Microscopic Polyangiitis; Immunosuppressive Agents; Antibodies, Antineutrophil Cytoplasmic; Churg-Strauss Syndrome; EosinophiliaCategories: Genetics; Drug Therapy; Therapeutic Use; Immunology; Blood; Metabolism
- Hoffman, Gary S RheumatologyDepartments of Rheumatology, and.Disclosed payments in 2021 from 3 biomedical companies, totalling $6,463, including $6,463 from PRINCIPIA BIOPHARMA INC.Subjects: Microscopic Polyangiitis; Immunosuppressive Agents; Methotrexate; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Murine-DerivedCategories: Drug Therapy; Therapeutic Use; Genetics; Immunology; Epidemiology; Diagnosis
- Seo, Philip RheumatologyDivision of Rheumatology, Johns Hopkins University, Baltimore, MD, USA. Top HospitalMedical school: Columbia University College of Physicians and Surgeons (MD, 1997)Medicare AcceptedDisclosed payments in 2021 from 4 biomedical companies, totalling $6,675, including $5,000 from Janssen Research & Development, LLCSubjects: Microscopic Polyangiitis; Churg-Strauss Syndrome; Immunosuppressive Agents; Eosinophilia; Genetic Predisposition to DiseaseCategories: Genetics; Therapeutic Use; Complications; Drug Therapy; Blood; Diagnosis
- Keogh, Karina A Pulmonary DiseaseDivision of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN. Electronic address: . Top HospitalSubjects: Asthma; Microscopic Polyangiitis; Antibodies, Monoclonal, Murine-Derived; Churg-Strauss Syndrome; Immunosuppressive AgentsCategories: Complications; Drug Therapy; Therapeutic Use; Administration & Dosage; Immunology; Mortality
- Geetha, Duvuru NephrologyDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Top HospitalSubjects: Microscopic Polyangiitis; Glomerulonephritis; Immunologic Factors; Immunosuppressive Agents; RituximabCategories: Therapeutic Use; Drug Therapy; Therapy; Complications; Etiology; Surgery
- Wechsler, Michael E Pulmonary DiseaseDivision of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, The NJH Cohen Family Asthma Institute, Denver, Colo. Electronic address: .Medical school: Other (MD, 1993)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 92/100Disclosed payments in 2021 from 152 biomedical companies, totalling $240,095.52, including $76,873.31 from AstraZeneca Pharmaceuticals LPSubjects: Churg-Strauss Syndrome; Antibodies, Monoclonal, Humanized; Eosinophilic Granuloma; Eosinophils; Anti-Inflammatory AgentsCategories: Drug Therapy; Immunology; Therapeutic Use; Diagnosis; Physiopathology; Cytology
- Ytterberg, Steven R RheumatologyMayo Clinic College of Medicine and Science, Rochester, Minnesota. Top HospitalDisclosed payments in 2021 from 3 biomedical companies, totalling $3,170, including $3,170 from PFIZER INC.Subjects: Microscopic Polyangiitis; Immunosuppressive Agents; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; EosinophiliaCategories: Genetics; Drug Therapy; Immunology; Therapeutic Use; Blood; Adverse Effects
- Sreih, Antoine G RheumatologyDivision of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA. Top HospitalMedical school: Other (MD, 1995)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100Disclosed payments from biomedical company (Stemline Therapeutics Inc.) in 2021 for $26.4Subjects: Microscopic Polyangiitis; Churg-Strauss Syndrome; Diabetes Insipidus, Neurogenic; Microbiota; Nasal CavityCategories: Genetics; Diagnosis; Microbiology; Blood; Diagnostic Imaging; Metabolism
- Fervenza, Fernando C NephrologyMayo Clinic and Foundation, Rochester, MN, USA. Top HospitalDisclosed payments in 2021 from 4 biomedical companies, totalling $8,640, including $3,600 from Otsuka Pharmaceutical Development & Commercialization, Inc.Subjects: Microscopic Polyangiitis; Antibodies, Monoclonal, Murine-Derived; Immunosuppressive Agents; Antibodies, Antineutrophil Cytoplasmic; Antibodies, MonoclonalCategories: Immunology; Drug Therapy; Therapeutic Use; Administration & Dosage; Methods
- Falk, Ronald J NephrologyUNC Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, NC. Top HospitalPhysician Highly CitedDisclosed payments in 2021 from 3 biomedical companies, totalling $6,000, including $6,000 from Vertex Pharmaceuticals IncorporatedSubjects: Microscopic Polyangiitis; Terminology as Topic; African Americans; Alleles; Churg-Strauss SyndromeCategories: Genetics; Diagnosis; Epidemiology; Immunology; Metabolism
- Koening, Curry L RheumatologyDivision of Rheumatology, University of Utah, Salt Lake City, UT, USA. Top HospitalSubjects: Microscopic Polyangiitis; Churg-Strauss Syndrome; Eosinophilia; Heart Diseases; Respiratory Tract DiseasesCategories: Genetics; Blood; Diagnostic Imaging; Epidemiology; Metabolism; Surgery
- Peikert, Tobias Pulmonary DiseaseDisclosed payments from biomedical company (AstraZeneca Pharmaceuticals LP) in 2021 for $1,950Subjects: Microscopic Polyangiitis; Antibodies, Monoclonal, Murine-Derived; Immunosuppressive Agents; Antibodies, Monoclonal; CyclophosphamideCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Complications; Diagnosis; Methods
- Dellaripa, Paul F RheumatologyBrigham and Womens Hospital, and Harvard University, Boston, Massachusetts. Top HospitalMedical school: University of Connecticut School of Medicine (MD, 1989)Medicare AcceptedSubjects: Eosinophilic Granuloma; Genetic Predisposition to Disease; HLA-DP beta-Chains; Lung; Respiratory SoundsCategories: Genetics; Diagnosis; Metabolism; Etiology; Immunology; Pathology
- Akuthota, Praveen Pulmonary DiseaseDivision of Pulmonary, Critical Care, and Sleep Medicine, Dept of Medicine, University of California, San Diego, La Jolla, CA, USA. Top HospitalMedical school: Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University (MD, 2001)Medicare AcceptedDisclosed payments in 2021 from 2 biomedical companies, totalling $5,422.75, including $3,575 from GlaxoSmithKline, LLC.Subjects: Churg-Strauss Syndrome; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Asthma; Drug HypersensitivityCategories: Immunology; Diagnosis; Drug Therapy; Therapeutic Use
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.